Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses - Napolitano, Valeria; Dabrowska, Agnieszka; Schorpp, Kenji; Mourão, André; Barreto-Duran, Emilia; Benedyk, Malgorzata; Botwina, Pawel; Brandner, Stefanie; Bostock, Mark; Chykunova, Yuliya; Czarna, Anna; Dubin, Grzegorz; et al. (Cell chemical biology, 2022)
Keywords: acriflavine; coronavirus; COVID-19; drug repurposing; PLpro; protease; protease inhibitor; SARS-CoV-2; structural biology; COVID-19; protease; SARS-CoV-2; protease inhibitor; drug repurposing; acriflavine; coronavirus; PLpro; structural biology; PL(pro)